Similar articles

• [Ticlopidine in heart surgery with cardiopulmonary by-pass (author's transl)].

  Renner C, Guilmet D, Curtet JM. Renner C, et al. Nouv Presse Med. 1980 Nov 15;9(43):3249-51. Nouv Presse Med. 1980. PMID: 7454568 Clinical Trial. French.
• [The use of platelet aggregation inhibitor in nephrodialysis].

  Armani U, Piana A, Griffanti-Bartoli F, Altomonte F. Armani U, et al. Arch Maragliano Patol Clin. 1979;35(2):63-5. Arch Maragliano Patol Clin. 1979. PMID: 400622 Review. Italian. No abstract available.
• Effect of ticlopidine on coagulation and platelet functions during hemodialysis with cuprophan membranes.

  Grekas D, Syrganis C, Romtsou S, Makris P, Tsakiris DA, Tourkantonis A. Grekas D, et al. Life Support Syst. 1985;3 Suppl 1:409-13. Life Support Syst. 1985. PMID: 2959822
• [Changes in arterial blood gases after hemodialysis and the influence of platelet antiaggregation].

  Méndez Martín A, Ortiz González A, Gutiérrez González JR. Méndez Martín A, et al. Med Clin (Barc). 1984 May 26;82(20):885-8. Med Clin (Barc). 1984. PMID: 6431205 Spanish. No abstract available.
• [Platelet anti-aggregant drugs and ischemic cardiopathy: evaluation of the effect on platelet aggregation and on antithrombin III].

  Avellone G, Mandalà V, Novo S, Pinto A, Riolo FP, Davì G, Raneli G. Avellone G, et al. Boll Soc Ital Cardiol. 1981;26(8):697-712. Boll Soc Ital Cardiol. 1981. PMID: 6289854 Review. Italian. No abstract available.